UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Lee Rosen, MD


Lee Rosen, MD

UCLA Physician Lee Rosen, MD specializes in Hematology & Oncology.
Hematology & Oncology
Language Spoken
English, Hebrew, Spanish
Hospital Affiliation
Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
State License Number
(888) ONC-UCLA (888-662-8252) Appointment center
(310) 829-5471 Office
Fax Number
(310) 582-6322
Voted Super Doctor

2020 Santa Monica Blvd, Suite 600
Santa Monica, CA 90404

Medical Oncology, American Board of Internal Medicine, 1997, 2010
Hematology/Oncology, UCLA School of Medicine, 1993 - 1996
Internal Medicine, UCLA School of Medicine, 1991 - 1993
Internal Medicine, UCLA School of Medicine, 1990 - 1991
MD, Baylor College of Medicine, 1990
Advanced Malignancies, Cancers of the Digestive Tract, Colorectal (colon, rectum and anus), Esophageal Cancer, Gastric Cancer, Gastrointestinal Malignancies, General Oncology, Hepatobiliary Cancers, Liver Cancer, Pancreas, Pancreatic Cancer, Phase 1 Clinical Trials, Unknown Primary
Department Affiliation
Provider, Hematology / Oncology, Gastrointestinal Oncology Program
Additional Information

Lee Rosen, MD, FACP is Health Sciences Clinical Professor of Medicine in the Division of Hematology-Oncology, Department of Medicine.  He has a longstanding interest in the treatment of pancreas and other gastrointestinal malignancies, specifically in the area of new drug development.  Dr. Rosen completed his residency and fellowship in hematology/oncology at the UCLA School of Medicine in 1996, joining the full-time faculty immediately thereafter.  He created and directed the Cancer Therapy Development Program, designed to coordinate translational/clinical research of new cancer treatments.  Some of the first drugs he and his team worked with were designed for gastrointestinal cancers, so he and colleagues created a group dedicated to treating these diseases in a coordinated fashion.  He also became interested in so-called "targeted" therapy, whereby cancers could be attacked by agents with a more rational drug design and the avoidance of toxicity to normal cells.  He has worked with angiogenesis inhibitors since their first appearance in the clinic and other molecules inhibiting signal transduction, others that try to harness the immune system to control cancer and still others that work by rational drug design.

Dr. Rosen and his group recently rejoined the Division of Hematology-Oncology at UCLA in 2011, where he now directs our Drug Development Program, co-directs the outpatient cancer center in Santa Monica and participates actively in the Gastrointestinal Malignancy multi-specialty groups.  He continues his active clinical practice and his search for new, hopefully less toxic and more effective ways of treating cancers.  His many clinical trials are open to patients with a range of malignancies and there are many new trials coming soon.

Board-certified in Internal Medicine and Medical Oncology, trained in Hematology, Dr. Rosen is also a member of the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR), the American Society of Hematology (ASH) and the American College of Physicians (ACP, where he is also a Fellow).

Back to top
Referring a Patient to UCLA
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.

Find out how to refer a patient
Lee Rosen, click here to update your profile.